LP-51

N/A

Report date: 2024/11/28 20:00:07
NME

Base Information

Drug NameLP-51
Drug Alias NameLP-51
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsSjogren's SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Pathogenic Biology Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Pathogenic Biology Chinese Academy Of Medical SciencesSoon Chun Hyang University
Inactive CompaniesN/A
Active IndicationsSjogren's SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A